HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Franz Kehl Selected Research

triphenyltetrazolium

9/2014The Role of Cyclooxygenase-1 and -2 in Sevoflurane-Induced Postconditioning Against Myocardial Infarction.
6/2013Endothelial nitric oxide synthase mediates the first and inducible nitric oxide synthase mediates the second window of desflurane-induced preconditioning.
4/2011Propofol inhibits desflurane-induced preconditioning in rabbits.
12/2009Differential role of Pim-1 kinase in anesthetic-induced and ischemic preconditioning against myocardial infarction.
10/2009Desflurane-induced preconditioning has a threshold that is lowered by repetitive application and is mediated by beta 2-adrenergic receptors.
3/2009Desflurane-induced postconditioning is mediated by beta-adrenergic signaling: role of beta 1- and beta 2-adrenergic receptors, protein kinase A, and calcium/calmodulin-dependent protein kinase II.
7/2008Differential role of calcium/calmodulin-dependent protein kinase II in desflurane-induced preconditioning and cardioprotection by metoprolol: metoprolol blocks desflurane-induced preconditioning.
2/2008Activation of mitochondrial large-conductance calcium-activated K+ channels via protein kinase A mediates desflurane-induced preconditioning.
11/2006Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice.
10/2006Desflurane-induced preconditioning against myocardial infarction is mediated by nitric oxide.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Franz Kehl Research Topics

Disease

24Infarction (Infarctions)
09/2014 - 01/2002
24Myocardial Infarction
09/2014 - 01/2002
8Ischemia
01/2012 - 11/2002
4Hyperglycemia
04/2008 - 01/2002
2Reperfusion Injury
01/2012 - 10/2009
2Myocardial Ischemia (Ischemic Heart Diseases)
02/2011 - 11/2002
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2004 - 04/2002
1Hiccup (Hiccups)
06/2011
1Coronary Occlusion
10/2009
1Wounds and Injuries (Trauma)
07/2009
1Heart Arrest (Cardiac Arrest)
02/2005
1Brain Ischemia (Cerebral Ischemia)
02/2005
1Hypoxia (Hypoxemia)
09/2004
1Cardiomyopathies (Cardiomyopathy)
12/2003
1Left Ventricular Dysfunction
12/2003
1Hyperemia
12/2002
1Diabetes Mellitus
06/2002
1Ventricular Tachycardia
05/2002

Drug/Important Bio-Agent (IBA)

19triphenyltetrazoliumIBA
09/2014 - 01/2002
14Desflurane (I 653)FDA Link
01/2012 - 09/2006
9Anesthetics (Anesthetic Agents)IBA
01/2012 - 01/2002
9IsofluraneFDA LinkGeneric
10/2009 - 01/2002
5Sevoflurane (Ultane)FDA LinkGeneric
09/2014 - 09/2004
4Evans Blue (Blue, Evans)FDA Link
06/2013 - 11/2006
3Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2008 - 12/2002
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2011 - 01/2011
2DNA (Deoxyribonucleic Acid)IBA
03/2011 - 01/2011
2ICI 118551IBA
10/2009 - 03/2009
2N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
03/2009 - 09/2006
2KN 93IBA
03/2009 - 07/2008
2esmolol (Brevibloc)FDA LinkGeneric
03/2009 - 09/2006
220-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
02/2004 - 04/2002
2Blood Glucose (Blood Sugar)IBA
06/2003 - 06/2002
2Ethanol (Ethyl Alcohol)IBA
04/2003 - 04/2002
2Adenosine Triphosphate (ATP)IBA
06/2002 - 01/2002
1SC 560IBA
09/2014
1Cyclooxygenase 1IBA
09/2014
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
09/2014
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
09/2014
1Anastrozole (Arimidex)FDA LinkGeneric
01/2012
1Aromatase (CYP19)IBA
01/2012
1Estrogens (Estrogen)FDA Link
01/2012
1phospholipid emulsion soybean oil (Intralipid)IBA
04/2011
1EmulsionsIBA
04/2011
1Propofol (Diprivan)FDA LinkGeneric
04/2011
1NitratesIBA
03/2011
1NitritesIBA
03/2011
1Adenosine Monophosphate (AMP)IBA
02/2011
1Protein Kinases (Protein Kinase)IBA
02/2011
1GlycogenIBA
02/2011
1Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
12/2009
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
12/2009
1Metoprolol (Toprol-XL)FDA LinkGeneric
07/2008
1Simvastatin (Zocor)FDA LinkGeneric
04/2008
1arginine methyl esterIBA
04/2008
1Troponin IIBA
11/2006
1Nitric Oxide Synthase (NO Synthase)IBA
10/2006
1Arginine (L-Arginine)FDA Link
10/2006
1Inhalation AnestheticsIBA
09/2004
1Vasoconstrictor AgentsIBA
02/2004
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2003
1Glucose (Dextrose)FDA LinkGeneric
06/2003
1Saline SolutionIBA
06/2003
1Acetylcysteine (Siran)FDA LinkGeneric
06/2003
1Adenosine (Adenocard)FDA LinkGeneric
04/2003
1ProstaglandinsIBA
12/2002
1Superoxides (Superoxide)IBA
12/2002
1AcidsIBA
12/2002
1propenylphosphonic acidIBA
12/2002
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
12/2002
1Oxygen (Dioxygen)IBA
05/2002
1Free RadicalsIBA
05/2002
1Potassium Channels (Potassium Channel)IBA
01/2002

Therapy/Procedure

6Microspheres (Microsphere)
06/2003 - 01/2002
1Vagus Nerve Stimulation
06/2011
1Laryngoscopes
07/2009
1Resuscitation
02/2005